Bioventus (BVS) EBIAT (2020 - 2025)
Historic EBIAT for Bioventus (BVS) over the last 6 years, with Q3 2025 value amounting to $4.0 million.
- Bioventus' EBIAT rose 16850.21% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 12323.2%. This contributed to the annual value of -$43.8 million for FY2024, which is 7759.34% up from last year.
- Per Bioventus' latest filing, its EBIAT stood at $4.0 million for Q3 2025, which was up 16850.21% from $9.3 million recorded in Q2 2025.
- Bioventus' EBIAT's 5-year high stood at $9.3 million during Q2 2025, with a 5-year trough of -$174.4 million in Q2 2023.
- In the last 5 years, Bioventus' EBIAT had a median value of -$6.4 million in 2024 and averaged -$24.2 million.
- Per our database at Business Quant, Bioventus' EBIAT crashed by 632124.28% in 2022 and then soared by 16850.21% in 2025.
- Quarter analysis of 5 years shows Bioventus' EBIAT stood at -$1.9 million in 2021, then crashed by 2270.47% to -$44.9 million in 2022, then soared by 82.94% to -$7.7 million in 2023, then surged by 134.13% to $2.6 million in 2024, then skyrocketed by 53.31% to $4.0 million in 2025.
- Its last three reported values are $4.0 million in Q3 2025, $9.3 million for Q2 2025, and -$3.3 million during Q1 2025.